Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Horizon Pharma

Horizon Pharma reported $624.7M in Trade Debtors for its fiscal quarter ending in March of 2023.

Trade Debtors Change
Amgen AMGN:US USD 5.74B 173M
AstraZeneca AZN:LN USD 10.8B 455M
Bausch Health Companies Inc VRX:CN USD 1.69B 102M
Cara Therapeutics CARA:US USD 7.26M 2.8M
Coherus Biosciences CHRS:US USD 101.46M 8.51M
Eli Lilly LLY:US USD 9.02B 463.2M
Endo International ENDP:US USD 465.71M 36.89M
Horizon Pharma HZNP:US USD 624.7M 51.65M
Novartis NOVN:VX USD 9.18B 849M
Pacira PCRX:US USD 93.2M 5.19M
Perrigo PRGO:US USD 770.4M 31.8M
Prestige Brands PBH:US USD 167.02M 9.93M
Revance Therapeutics RVNC:US USD 15.37M 4.03M
Supernus Pharmaceuticals SUPN:US USD 143.57M 21.93M
Takeda 4502:JP JPY 681.69B 98.18B
Xeris Pharmaceuticals Inc XERS:US USD 30.86M 30K
Zoetis ZTS:US USD 1.19B 29M